Rebecca Hubbard

Professor, Clinician-Educator

University of Pennsylvania
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rebecca Hubbard is a Professor and Clinician-Educator at the University of Pennsylvania, USA. Her research areas include the epidemiology of liver disease, diabetic retinal disease, and the impacts of chemotherapy shortages on cancer patients. She also focuses on health equity in cancer diagnostics and the evaluation of observational study methodologies.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background Annual surveillance mammography is recommended for women with a personal history of breast cancer. Risk prediction models that estimate mammography failures such as interval second breast cancers could help to tailor surveillance imaging regimens to women’s individual risk profiles. Methods In a cohort of women with a history of breast cancer receiving surveillance mammography in the Breast Cancer Surveillance Consortium in 1996-2019, we used Least Absolute Shrinkage and Selection Operator (LASSO)-penalized regression to estimate the probability of an interval second cancer (invasive cancer or ductal carcinoma in situ) in the 1 year after a negative surveillance mammogram. Based on predicted risks from this one-year risk model, we generated cumulative risks of an interval second cancer for the five-year period after each mammogram. Model performance was evaluated using cross-validation in the overall cohort and within race and ethnicity strata. Results In 173 290 surveillance mammograms, we observed 496 interval cancers. One-year risk models were well-calibrated (expected/observed ratio = 1.00) with good accuracy (area under the receiver operating characteristic curve = 0.64). Model performance was similar across race and ethnicity groups. The median five-year cumulative risk was 1.20% (interquartile range 0.93%-1.63%). Median five-year risks were highest in women who were under age 40 or pre- or perimenopausal at diagnosis and those with estrogen receptor-negative primary breast cancers. Conclusions Our risk model identified women at high risk of interval second breast cancers who may benefit from additional surveillance imaging modalities. Risk models should be evaluated to determine if risk-guided supplemental surveillance imaging improves early detection and decreases surveillance failures.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (16)

Martin Eklund

Associate professor

Karolinska Institutet

SWEDEN
View details

Hari Vigneswaran

Karolinska Institutet

SWEDEN
View details

Diana Miglioretti

Professor and Division Chief of Biostatistics

University of California, Davis

UNITED STATES
View details

Louise Henderson

Professor

University of North Carolina

UNITED STATES
View details

Lainie Martin

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details

Ronac Mamtani

University of Pennsylvania

UNITED STATES
View details

Janie M Lee

-

UNITED STATES
View details

Joseph Hogan

Brown University

UNITED STATES
View details

Jason A. Roy

Rutgers University

UNITED STATES
View details

Oluwadamilola Fayanju

University of Pennsylvania

UNITED STATES
View details

Marina Serper

Assistant Professor of Medicine

University of Pennsylvania

UNITED STATES
View details

Ravi Parikh

Assistant Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES
View details

Kossi Edoh

Professor

North Carolina A&T State University

UNITED STATES
View details

Nandita Mitra

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES
View details

Christopher Li

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Jessie Torgersen

Assistant Professor of Medicine

University of Pennsylvania Perelman School of Medicine

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.